India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
Published in Indian Journal of Medical Research, study classifies nearly 10% prescriptions as 'unacceptable', says such lapses can lead to adverse drug reactions & risk patient health.
Swiss drugmaker Roche Pharma says Ocrelizumab can help manage multiple sclerosis & impede disability progression. Doctors welcome launch but caution against potential side effects.
The two drugs – Leqembi and Donanemab – are the first to offer real hope of slowing the fatal disease for 6.5 million Americans living with the disease.
At least 70 children died from acute kidney injury in Gambia last year, cases the WHO linked to medicines made by Indian drugmaker Maiden Pharmaceuticals.
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
BJP’s fate in the second phase of 2024 Lok Sabha election will be decided in Karnataka, Rajasthan, and Maharashtra, where it performed very well in 2019 but faces a stiff competition now.
The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.
Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.
COMMENTS